Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group

被引：0
|
作者：
Zagouri, F. [1 ]
Bamias, A. [5 ]
Papakostas, P. [2 ]
Karadimou, A. [1 ]
Bournakis, E. [1 ]
Dimopoulos, M. [1 ]
Fountzilas, G. [3 ]
Papadimitriou, C. A. [4 ]
机构：
[1] Univ Athens, Sch Med, Dept Clin Therapeut, GR-11527 Athens, Greece
[2] Hippocrateio Hosp, Dept Med Oncol, Athens, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Thessaloniki, Greece
[4] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece
[5] Univ Athens, Sch Med, Dept Clin Therapeut 1, GR-11527 Athens, Greece
来源：
BREAST | 2009年 / 18卷
关键词：
D O I：
10.1016/S0960-9776(09)70210-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [41] Phase II study biweekly paclitaxel, doxorubicin and gemcitabine as first line chemotherapy for metastatic breast cancer (MBC).
    Sanchez-Rovira, P
    González, E
    Porras, I
    Jaén, A
    Medina, B
    Fernández, M
    Mohedano, N
    Lozano, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S52 - S52
  • [42] A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: A Hoosier Oncology Group study
    Ganjoo, KN
    Gordon, MS
    Sandler, AB
    Warner, RE
    Fife, K
    Poirier, S
    Seshadri, R
    Loehrer, PJ
    ONCOLOGY, 2002, 62 (04) : 299 - 304
  • [43] A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: A gynecologic oncology group study
    Miller, Brigitte E.
    Blessing, John A.
    Stehman, Frederick B.
    Shahin, Mark S.
    Yamada, S. Diane
    Secord, Angeles Alvarez
    Warshal, David P.
    Abulafia, Ovadia
    Richards, William E.
    Van Le, Linda
    GYNECOLOGIC ONCOLOGY, 2010, 118 (02) : 139 - 144
  • [44] First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group
    Fountzilas, G
    Dimopoulos, AM
    Papadimitriou, C
    Kalogera-Fountzila, A
    Aravantinos, G
    Bafaloakos, D
    Athanassiades, A
    Nicolaides, C
    Keramopoulos, A
    Pavlidis, N
    Kosmidis, P
    Skarlos, D
    ANNALS OF ONCOLOGY, 1998, 9 (09) : 1031 - 1034
  • [45] Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer
    Brell, Joanna M.
    Matin, Khalid
    Evans, Terry
    Volkin, Robert L.
    Kiefer, Gauri J.
    Schlesselman, James J.
    Dranko, Shelley
    Rath, Linda
    Schmotzer, Amy
    Lenzner, Diana
    Ramanathan, Ramesh K.
    ONCOLOGY, 2009, 76 (04) : 270 - 274
  • [46] A Phase II Study of Weekly Paclitaxel Plus Gemcitabine as a Second-Line Therapy in Patients with Metastatic or Recurrent Small Cell Lung Cancer
    Yun, Tak
    Kim, Heung Tae
    Han, Ji-Youn
    Yoon, Sung Jin
    Kim, Hyae Young
    Nam, Byung-Ho
    Lee, Jin Soo
    CANCER RESEARCH AND TREATMENT, 2016, 48 (02): : 465 - 472
  • [47] Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group
    Gogas, Helen
    Pectasides, Dimitrios
    Kostopoulos, Ioannis
    Lianos, Evangelos
    Skarlos, Dimosthenis
    Papaxoinis, George
    Bobos, Mattheos
    Kalofonos, Haralabos P.
    Petraki, Kalliopi
    Pavlakis, Kitty
    Bafaloukos, Dimitrios
    Fountzilas, George
    CLINICAL BREAST CANCER, 2010, 10 (03) : 230 - 237
  • [48] Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: A multicenter phase II study
    Kakolyris, S.
    Kalbakis, K.
    Potamianou, A.
    Malamos, N.
    Vamvakas, L.
    Christophillakis, C.
    Tselepatiotis, E.
    Giassas, S.
    Mavrousis, D.
    Amarantidis, K.
    Georgoulias, V.
    ONCOLOGY, 2006, 70 (04) : 273 - 279
  • [49] Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: A multicenter phase II study
    Kakolyris
    ONCOLOGY, 2006, 71 (3-4) : 203 - 203
  • [50] Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial
    Dongiovanni, V
    Buffoni, L
    Berruti, A
    Dongiovanni, D
    Grillo, R
    Barone, C
    Addeo, A
    Camilla, F
    Bertetto, O
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (02) : 203 - 209
12345